HBOC-201

BIOLOGICAL4 trials

Sponsors

Englewood Hospital and Medical Center, Johns Hopkins University, Mauricio Lynn, Michael Boisen

Conditions

AnemiaAnemia Severe

Unknown Phase

Expanded Access Study of HBOC-201 (Hemopure) for the Treatment of Life-Threatening Anemia

Enrolling by invitationNCT01881503

Englewood Hospital and Medical CenterAnemia

Start: 2013-10-31End: 2026-12-31Target: 50Updated: 2025-04-13

Expanded Access Protocol Using HBOC-201

Johns Hopkins UniversityAnemia

Updated: 2025-10-23

HBOC-201 Expanded Access Protocol for Life-threatening Anemia for Whom Allogeneic Blood Transfusion is Not an Option

Mauricio LynnAnemia

Updated: 2024-12-20

Expanded Access IND Administration of HBOC-201 in Patients With Severe Acute Anemia

Michael BoisenAnemia Severe

Updated: 2026-07-20